With that in mind, here's why investors might want to take a look at Wells Fargo (NYSE: WFC), Teva Pharmaceutical Industries (NYSE: TEVA), and one other stock that is perhaps the best value of all... The market's fears may be overblown To say that generic drug maker Teva Pharmaceutical Industries has been beaten down lately would be a dramatic understatement. There are a few reasons for this: Competitive pressures have hurt Teva's profit margins on key generic drugs, and there are many outstanding lawsuits related to Teva's involvement in price inflation and opioid sales.